Medicare Enrolled

Dr. Nicola Hanania, MD

Pulmonary Disease · Houston, TX
6620 MAIN ST, Houston, TX 77030
7137982500
Registered in NPPES since 2006
NPI: 1851471114 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hanania from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanania? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hanania

Dr. Nicola Hanania is a pulmonary disease specialist in Houston, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Hanania received a total of $1,043,714 from 25 pharmaceutical and/or device companies across 603 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hanania is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $1,043,714 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,043,714
Total received (2018-2024)
Avg $149,102/year across 7 years
Top 1% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
603
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$312,942
2023
$112,755
2022
$77,257
2021
$34,781
2020
$106,807
2019
$178,611
2018
$220,561

Payments by company (2024)

SANOFI-AVENTIS U.S. LLC
$183,866
GENZYME CORPORATION
$75,973
Regeneron Healthcare Solutions, Inc.
$30,975
GlaxoSmithKline, LLC.
$9,238
AstraZeneca Pharmaceuticals LP
$5,856
Regeneron Pharmaceuticals, Inc.
$4,212
Genentech USA, Inc.
$2,779
Merck Sharp & Dohme LLC
$43
Top 3 companies account for 92.9% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$354,361
GENZYME CORPORATION
$156,077
Regeneron Healthcare Solutions, Inc.
$125,545
GlaxoSmithKline, LLC.
$77,268
AstraZeneca Pharmaceuticals LP
$71,161
AstraZeneca AB
$39,054
F. Hoffmann-La Roche AG
$35,569
Novartis Pharma AG
$26,489
AstraZeneca UK Limited
$25,365
Regeneron Pharmaceuticals, Inc.
$21,539
Mylan Specialty L.P.
$19,764
Teva Pharmaceuticals USA, Inc.
$18,325
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,283
Genentech, Inc.
$13,391
SANOFI US SERVICES INC.
$13,363
Genentech USA, Inc.
$12,352
Boehringer Ingelheim International GmbH
$7,580
Amgen Inc.
$3,316
Novartis Pharmaceuticals Corporation
$3,216
Rigel Pharmaceuticals, Inc.
$1,200
Mylan Inc.
$824
DERMIRA, INC.
$595
Merck Sharp & Dohme LLC
$43
BOSTON SCIENTIFIC CORPORATION
$20
Gilead Sciences, Inc.
$14
Top 3 companies account for 60.9% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO ELLIPTA · AirDuo Digihaler · BEVESPI AEROSPHERE · BREZTRI AEROSPHERE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · FASENRA · FEVIPIPRANT · GENERAL PULMONARY · IGE025A · IGE025A_XOLAIR _RESPIRATORY · IMFINZI · NO PRODUCT DISCUSSED · NUCALA · Non-Covered Product · OFEV · PULMICORT RESPULES · Perforomist · ProAir Digihaler · QBREXZA · QVA149A · SPIRIVA · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · Tavalisse · Veklury · WINREVAIR · Xofluza · Xolair · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
136
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hanania is a pulmonary disease specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Hanania receive payments from pharmaceutical companies?
Yes. Dr. Hanania received a total of $1,043,714 from 25 companies across 603 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Hanania) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Houston
Browse pulmonary diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →